Related Experiment Video
Updated: Apr 3, 2026
09:21
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
12.8K
Neurothrombectomy trial results: stroke systems, not just devices, make the difference
J Mocco1, Kyle M Fargen2, Mayank Goyal3
1Department of Neurosurgery, Mount Sinai Hospital, New York, NY, USA.
Summary
New intra-arterial therapies significantly improve stroke outcomes, but require specialized stroke centers. Advanced neurothrombectomy devices and comprehensive stroke systems are key for successful treatment and wider patient access.
Area of Science:
- Neurology
- Interventional Radiology
- Public Health
Background:
- Emergent stroke management has been revolutionized by recent randomized trials.
- Intra-arterial therapies show significant benefits over medical management alone.
- New generation neurothrombectomy devices played a role in trial success.
Purpose of the Study:
- To highlight the transformative impact of intra-arterial therapies in stroke management.
- To emphasize the importance of specialized stroke systems for achieving trial outcomes.
- To advocate for broader implementation of advanced stroke care.
Main Methods:
- Analysis of four recent randomized trials comparing intra-arterial therapies to medical management.
- Evaluation of the role of neurothrombectomy devices and hospital stroke systems.
- Assessment of factors contributing to patient outcomes in stroke trials.
Main Results:
- Intra-arterial therapies demonstrated overwhelming benefits in stroke treatment.
- Patient outcomes were linked to complex, resource-rich, team-based stroke systems.
- Neurothrombectomy devices were critical but not the sole determinant of success.
Conclusions:
- Stroke treatment requires specialized facilities with robust resources and organization.
- Certification processes for stroke centers are needed to ensure quality care.
- Education and investment are crucial for expanding access to advanced stroke treatments.
